Glooko and Hedia's New Collaboration to Boost Diabetes Management Through Personalized Insulin Solutions

Glooko and Hedia Join Forces for Improved Diabetes Management

In a groundbreaking partnership, Glooko, Inc. and Hedia have unveiled a new interoperable solution aimed at enhancing diabetes management for patients who require bolus insulin dosing. This innovative collaboration merges connected care, remote patient monitoring, and digital therapeutics to create a user-friendly system for individuals managing Type 1 and Type 2 diabetes. The exciting new launch is currently available in the United Kingdom and will soon be rolled out to other European nations.

A bolus is defined as an additional amount of insulin taken to counteract a predicted rise in blood glucose levels, often triggered by meals or snacks. Typically, one unit of insulin is required to decrease blood glucose levels by about 50 mg/dl, although this can vary significantly among individuals. Many patients, especially those without insulin pumps, face challenges in accurately determining the right bolus dose, making effective diabetes management more complex.

With the integration of Hedia's Diabetes Assistant into the Glooko platform, patients can easily share essential health data with their healthcare providers (HCPs). This data encompasses blood glucose readings, insulin dosages, carbohydrate intake, exercise logs, weight, and blood pressure, which contributes to a comprehensive overview of a patient’s health. This synergy offers not only personalized support in calculating insulin doses but also helps in achieving consistent blood glucose levels—an essential objective for those managing diabetes.

Healthcare providers gain more visibility into their patients' health conditions via seamless access to vital information like blood glucose trends, insulin administration, and carbohydrate consumption. This streamlined approach to managing multiple daily injections (MDI) not only enhances patient outcomes but also improves overall efficiency for healthcare providers, whether in remote or in-person care settings.

Glooko's Chief Executive Officer, Mike Alvarez, expressed his enthusiasm about bringing this personalized innovation to patients: "We're very pleased to bring this algorithm-driven, personalized innovation to diabetes patients and their healthcare teams through our partnership with Hedia. Backed by extensive clinical data that supports Hedia’s efficacy, this solution offers an alternative for those unable to access insulin pumps, ensuring more effective management of MDI therapy."

On the other hand, Lars Christian Lund, CEO of Hedia, highlighted the alignment of their goals, stating, "This joint offering is perfectly aligned with Hedia’s vision to improve the quality of life for people with diabetes and make the best diabetes management tools accessible. Additionally, we’ve recently achieved MDR certification in Europe, which guarantees patients and their care teams are getting the best solutions available."

About Hedia

Hedia is a premier digital therapeutics company focused on diabetes management, dedicated to aiding individuals with insulin-dependent diabetes in effectively controlling their condition. From its inception, Hedia’s mission has been to simplify life for those suffering from diabetes. By leveraging personal habits and inputs, the Hedia Diabetes Assistant app generates tailored insulin recommendations while considering various factors involved in diabetes management, such as blood glucose tracking, active insulin monitoring, carbohydrate counting, and activity tracking.

About Glooko

Glooko is at the forefront of enhancing health outcomes for those with chronic conditions through its intelligent, connected care and life sciences platform. Its proven technology revolutionizes patient-provider connections, driving engagement and adherence via digital therapeutics and accelerating clinical trial processes. Currently, Glooko's platform is utilized in over 30 countries and more than 10,000 clinical settings, with over 4.4 million users worldwide.

For more information about these innovations in diabetes management, visit glooko.com.